HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 772.248K |
Day Range | - - - |
52 Wk Range | 0.410 - 2.050 |
Market Cap | $88.174M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 0.33% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Other companies in HOOKIPA Pharma’s space includes: Curis (NASDAQ:CRIS), Cellectar Biosciences (NASDAQ:CLRB), Burning Rock Biotech (NASDAQ:BNR), Armata Pharmaceuticals (AMEX:ARMP) and Barinthus Biotherapeutics (NASDAQ:BRNS).
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by HC Wainwright & Co. on Friday, April 26, 2024. The analyst firm set a price target for 5.00 expecting HOOK to rise to within 12 months (a possible 461.10% upside). 10 analyst firms have reported ratings in the last year.
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.8911 last updated April 26, 2024 at 7:59 PM EDT.
There are no upcoming dividends for HOOKIPA Pharma.
HOOKIPA Pharma’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for HOOKIPA Pharma.
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.